S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|GSK and Genmab Receive CHMP Positive Opinion for Arzerra(tm) in Combination with Chlorambucil or Bendamustine as a First-line Treatment for Patients with Chronic Lymphocytic Leukemia (CLL) Who Are Not Eligible for Fludarabine-based Therapy|
|GSK and Genmab Announce Topline Results from a Pivotal Head to Head Study of Ofatumumab in Combination With Chemotherapy vs Rituximab in Combination with Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma|
|UPDATE: Vodafone pulls FTSE 100 from 14-year high (2014/5/15)|
|UPDATE: European stocks slide on global growth worries (2014/5/15)|
|UPDATE: European stocks waver after GDP misses forecast (2014/5/15)|
|Isis Pharmaceuticals Earns $3.0 Million from GSK|
|New Studies Demonstrate Benefits of Robotics for Lung Surgery (2014/4/28)|
|OncoMed Receives Orphan Drug Designation From the FDA for Demcizumab in Pancreatic Cancer|
|ChemoCentryx Announces Financial Results for the First Quarter Ended March 31, 2014|
|Theravance, Inc. Announces Effectiveness of Form 10 Registration Statement of Theravance Biopharma, Inc.|
Click above to view more mutual fund data and stats for gsk - GlaxoSmithKline PLC.